title: [HAS-BLED shows bleeding risk in ischemic stroke and atrial fibrillation. But adjustments are needed for safer assessment, according to quality study].
authors.affiliation: Akademiska sjukhuset, Uppsala. jinan.al-shakarchi@akademiska.se
authors.forename: Jinan
authors.initials: J
authors.lastname: Alshakarchi
authors.forename: Andreas
authors.initials: A
authors.lastname: Terént
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000600:supply & distribution / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D012189:Retrospective Studies; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D020521:Stroke / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D013548:Sweden / Q000453:epidemiology; D013923:Thromboembolism / Q000188:drug therapy / Q000517:prevention & control
chemical_list: D000925:Anticoagulants